Related Experiment Video
Updated: Dec 12, 2025

08:13
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
7.0K
Acquired Haemophilia Associated with Urticarial Vasculitis
1Internal Medicine Unit, General Hospital Alés, Alés, France.
European Journal of Case Reports in Internal Medicine
|August 14, 2020
Summary
Acquired haemophilia (AHA), a rare autoimmune disorder, can cause severe bleeding. This case highlights a rare association between AHA and urticarial vasculitis, successfully managed with specific treatments.
Area of Science:
- Autoimmune diseases
- Hematology
- Immunology
Background:
- Acquired haemophilia (AHA) is a rare autoimmune disorder characterized by autoantibodies inhibiting factor VIII (FVIII) activity.
- The incidence of acquired FVIII inhibitors is approximately 1 case per million per year.
- AHA is associated with various conditions including autoimmune diseases, malignancies, drug treatments, pregnancy, and infections.
Purpose of the Study:
- To report a rare case of acquired haemophilia (AHA) associated with urticarial vasculitis.
- To describe the clinical presentation and successful management of this rare condition.
Main Methods:
- Case report of a 59-year-old woman.
- Diagnosis of acquired haemophilia (AHA) and urticarial vasculitis.
- Treatment with factor eight inhibitor bypassing activity (FEIBA) and prednisolone.
Main Results:
- The patient presented with cutaneous and muscle haematomas.
- The condition was secondary to acquired haemophilia (AHA) in association with urticarial vasculitis.
- Successful treatment was achieved with FEIBA and prednisolone.
Conclusions:
- Acquired haemophilia (AHA) is a rare autoimmune disease.
- AHA can lead to severe, life-threatening hemorrhage.
- The association between AHA and urticarial vasculitis is exceptionally rare.
Related Concept Videos
Disorders of Hemostasis
1.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.4K
Rheumatic Heart Disease I: Introduction
279
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
279
Extrinsic and Intrinsic Pathways of Hemostasis
11.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.2K
Venous Thrombosis III: Interprofessional Care
179
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
179
Introduction to Hemostasis
12.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
12.3K

